Clinical Trials Directory

Trials / Sponsors / MyoKardia, Inc.

MyoKardia, Inc.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
CompletedClinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyop
Obstructive Hypertrophic Cardiomyopathy
Phase 32018-05-29
CompletedA Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
Non-obstructive Hypertrophic Cardiomyopathy
Phase 22018-03-30
CompletedA Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491
Dilated Cardiomyopathy
Phase 12017-01-16
CompletedA Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy a
Cardiomyopathy, Hypertrophic Obstructive, Left Ventricular Outflow Tract Obstruction
Phase 22016-08-01
CompletedSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of MYK-461 in Hea
Healthy
Phase 12015-08-01
CompletedSingle Ascending Dose Study of MYK-461 in Healthy Volunteers
Healthy
Phase 12015-01-01
CompletedStudy Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Hypertrophic Cardiomyopathy
Phase 12014-12-01